Bridge Pharmaceuticals raises $35M for China Operations

“Bridge Pharmaceuticals, which does contract drug research in China for other companies, said Tuesday it raised $35 million in its second round of venture funding. A new investor, Granite Global Ventures, gave money in this round, as did investors from its previous round. Helen Wong of Granite Global took a seat on Bridge’s board as part of the deal. She works out of Granite Global’s office in Shanghai. Bridge will spend the money raised on its research operations in China.”